AVBP

NASDAQ · Biotechnology

Arrivent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$22.18

+0.16 (+0.73%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +15.4% upside

Low Target $15.99

Average Target $25.60

High Target $32.44

Current Price $22.18

Current
$22.18

Target
$25.60

$15.99 $25.60 avg $32.44

Scenario Analysis

Bear Case

$15.99

-27.9%

Low target

Base Case

$25.60

+15.4%

Avg target

Bull Case

$32.44

+46.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$27.22

-18.5% from high

52-Week Low

$15.47

+43.4% from low

Target vs 52W High

$25.60

-6.0% vs high

Next Earnings Report

Mar 26, 2026 · Before Market Open

Today

EPS Est: $-0.86

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+22.0%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+163.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.9%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.9%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.2%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%